Back to today’s briefing

Story perspectives

Cannabinoid CBD: Promise for Psychosis, Anxiety, and Insomnia

8/29/2025

36 3

Summary

Story summary

CBD may reduce psychotic symptoms by boosting anandamide levels, with effective doses ranging from 800-1500 mg/day.
Preclinical studies indicate CBD can relieve pain, but human trials show mixed results.
Stronger evidence supports CBD's effectiveness for anxiety and insomnia compared to chronic pain or sleep quality.
Additional research is necessary to align animal study results with human clinical outcomes.

1 of 1

Story summary

CBD may reduce psychotic symptoms by boosting anandamide levels, with effective doses ranging from 800-1500 mg/day.
Preclinical studies indicate CBD can relieve pain, but human trials show mixed results.
Stronger evidence supports CBD's effectiveness for anxiety and insomnia compared to chronic pain or sleep quality.
Additional research is necessary to align animal study results with human clinical outcomes.